Revegen

400 Farmington Avenue
Farmington, CT 06030
http://revegencorp.com/index.htm

Revegen is dedicated to the discovery and implementation of new, cutting-edge technologies that enhance productivity of pharmaceutical drug discovery research. We believe that the best strategy through which to accomplish this goal is to invest in the innovation of the R&D processes and in better management of risks associated with early discovery research. Our proprietary technologies enable discovery of new medicines on the basis of principles that dictate molecular recognition between drugs and therapeutic targets, delivering targeted therapies which address the most pressing medical problems associated with cancer, drug-resistant bacterial infections and other diseases. The company has created a discovery platform in the center of which is our Probability Density Imaging Technology (PDICAD) that provides high accuracy to predict structural and stereo-electronic compatibility between a therapeutic target and molecular building blocks. Our approach optimizes simultaneously a drug’s affinity toward a designated therapeutic target, its pharmacokinetic properties and its safety profile, thereby creating a highly convergent and resource efficient discovery process.